Gene · 23765
Papers3,930
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,181 to 1,200 of 3,930
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CD5L Secreted by Macrophage on Atherosclerosis Progression Based on Lipid Metabolism Induced Inflammatory Damage. | Arch Immunol Ther Exp (Warsz) | 2022 | 35249136 | PubTator, text mining | PubMed |
| A Novel Combined Use of Dupilumab for Treatment of Aggressive Refractory Pemphigus Vulgaris Complicated With Pulmonary Tuberculosis: A Case Report and the RNA-seq Analysis. | Front Immunol | 2022 | 35222408 | PubTator, text mining | PubMed |
| The Molecular Mechanisms of Intestinal Inflammation and Fibrosis in Crohn's Disease. | Front Physiol | 2022 | 35222098 | PubTator, text mining | PubMed |
| Monocyte Gene and Molecular Expression Profiles Suggest Distinct Effector and Regulatory Functions in Beninese HIV Highly Exposed Seronegative Female Commercial Sex Workers. | Viruses | 2022 | 35215954 | PubTator, text mining | PubMed |
| Response to Vaccines in Patients with Immune-Mediated Inflammatory Diseases: A Narrative Review. | Vaccines (Basel) | 2022 | 35214755 | PubTator, text mining | PubMed |
| 29 m6A-RNA Methylation (Epitranscriptomic) Regulators Are Regulated in 41 Diseases including Atherosclerosis and Tumors Potentially via ROS Regulation - 102 Transcriptomic Dataset Analyses. | J Immunol Res | 2022 | 35211628 | PubTator, text mining | PubMed |
| Astrocytes and Inflammatory T Helper Cells: A Dangerous Liaison in Multiple Sclerosis. | Front Immunol | 2022 | 35211120 | PubTator, text mining | PubMed |
| Maternal and Adult Interleukin-17A Exposure and Autism Spectrum Disorder. | Front Psychiatry | 2022 | 35211045 | PubTator, text mining | PubMed |
| Metabolic Syndrome and Its Components in Psoriatic Arthritis. | Open Access Rheumatol | 2022 | 35210876 | PubTator, text mining | PubMed |
| Gene Expression Profile Analyses of the Skin Response of Balb/c-Nu Mice Model Injected by Staphylococcus aureus. | Clin Cosmet Investig Dermatol | 2022 | 35210800 | PubTator, text mining | PubMed |
| Antigen-Presenting Cells in Psoriasis. | Life (Basel) | 2022 | 35207521 | PubTator, text mining | PubMed |
| Orchestrated Cytokines Mediated by Biologics in Psoriasis and Its Mechanisms of Action. | Biomedicines | 2022 | 35203707 | PubTator, text mining | PubMed |
| Impact of Adalimumab Treatment on Interleukin-17 and Interleukin-17 Receptor Expression in Skin and Synovium of Psoriatic Arthritis Patients with Mild Psoriasis. | Biomedicines | 2022 | 35203534 | PubTator, text mining | PubMed |
| Chronic Mucocutaneous Candidiasis due to Signal Transducer and Activator of Transcription 1 (STAT 1) Mutation in an Indian Patient - A Case Report. | Indian Dermatol Online J | 2022 | 35198474 | PubTator, text mining | PubMed |
| Can epigenetics shine a light on the biological pathways underlying major mental disorders? | Psychol Med | 2022 | 35193719 | PubTator, text mining | PubMed |
| Safety of Brodalumab in Plaque Psoriasis: Integrated Pooled Data from Five Clinical Trials. | Acta Derm Venereol | 2022 | 35191512 | PubTator, text mining | PubMed |
| Interleukin-17RA blockade by brodalumab decreases inflammatory pathways in hidradenitis suppurativa skin and serum. | Br J Dermatol | 2022 | 35191018 | PubTator, text mining | PubMed |
| Immune-related adverse events (irAEs) in ankylosing spondylitis (AS) patients treated with interleukin (IL)-17 inhibitors: a systematic review and meta-analysis. | Inflammopharmacology | 2022 | 35188599 | PubTator, text mining | PubMed |
| In silico Analysis of SARS-CoV-2 ORF8-Binding Proteins Reveals the Involvement of ORF8 in Acquired-Immune and Innate-Immune Systems. | Front Med (Lausanne) | 2022 | 35178414 | PubTator, text mining | PubMed |
| Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications. | Nat Commun | 2022 | 35177642 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23765/papers?page=60